Total Funding
45
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 45 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
About the Company
Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs. Their PI3K inhibitors are used to treat tumors and have the potential to treat cancers of the brain, lungs, and hemological systems.
